As capital sources become more elusive, companies are increasingly exploring creative methods to structure transactions and it is more important than ever to find successful transaction structures that build value. This session will focus on unique financial structures that have been utilized to leverage industry and financing opportunities.
This panel will review the following:
Combined deferred mergers and product development licenses
Debt transactions
Equity lines
The use of business incubators
Moderator:
- Richard A. Kaufman, Partner, Foley & Lardner
Panelists:
- Mark Benedyk, Head of The Pfizer Incubator LLC
- Donna Tempel, Ph.D., President and CEO, Drais Pharmaceuticals
- Jack Lief, Co-Founder, Chairman, President & CEO, Arena Pharmaceuticals
- Michael White, Deal Team Leader, Silicon Valley Bank
Related Insights
February 9, 2026
Foley Viewpoints
Federal Court Enjoins Oregon's Extended Producer Responsibility Law—a Bellwether Moment for All Seven EPR States
On February 6, a federal judge in Oregon quietly issued a two‑page order that might have initially appeared to be a mundane procedural…
February 9, 2026
Energy Current
Venezuela’s New Hydrocarbon Framework: Key Considerations for Energy, Financial, and Sanction Sensitive Businesses
We thank our colleagues Arnoldo Troconis and Carlos Omaña at D’Empaire Reyna Abogados—Foley’s Latin American Network member firm in…
February 9, 2026
Innovative Technology Insights
California Rolls Out New Venture Capital Diversity Reporting Requirements
California’s new law, Fair Investment Practices by Venture Capital Companies, will require diversity reporting by venture capital and similar investment firms with a California nexus beginning in 2026.